Scientists are constantly been working on improving the vaccine efficacy ever since the new strain was reported in UK and South Africa. These new versions are coming up to battle new variants of the potent coronavirus.
As per the latest information, 128 research papers are being published every day to know about the new covid virus. Sources cited latest update citing confirmation from Oxford University that the scientific team behind the vaccine from Oxford and AstraZeneca Plc is undertaking feasibility studies to reconfigure the technology. Currently, the new version’s vaccine pilot testing is being held at Bournemouth International Center.
British Prime Minister Boris Johnson has announced that the country’s Medicines and Health Regulatory Agency (MHRA) is in the process of analysing the data reports and is likely to approve new genetic versions of COVID-19 vaccines. Reportedly, the PM is in intensive discussions with the researchers.
The scientists have been vigilantly assessing to figure out how rapidly they could reconfigure their ChAdOx vaccine platform and its impact on immunity, the report said. Sarah Gilbert, one of the leading researchers at Oxford however asserted that there is no much necessity to adapt the vaccine in response to British variant labelled as B117. If alterations in vaccine genetic information is required, it merely takes a day before growing the vaccine in cell culture in the laboratory, the scientist added.